Zonios Dimitrios I, Falloon Judith, Huang Chiung-Yu, Chaitt Doreen, Bennett John E
From Clinical Mycology Section, Laboratory of Clinical Infectious Diseases (DIZ, JEB); Laboratory of Immunoregulation (JF); and Biostatistics Research Branch (C-YH), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; and Critical Care Medicine Department (DC), Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland.
Medicine (Baltimore). 2007 Mar;86(2):78-92. doi: 10.1097/md.0b013e31803b52f5.
We reviewed the cases of 11 patients with cryptococcosis and idiopathic CD4 lymphocytopenia (ICL) referred to our institution in the previous 12 years, as well as 42 similar cases reported in the literature, to assess the characteristics of the infection in this population. Cryptococcosis in 53 patients with ICL had features in common with cryptococcosis in previously normal patients. ICL patients had a slight male predominance (1.2:1) and a median age of presentation of 41 years (range, 4.5-85 yr). Initial cerebrospinal fluid findings showed glucose below 40 mg/dL in 60% of the patients, a median pleocytosis of 59 white blood cells/mm (range, 0-884), and protein of 156 mg/dL (range, 25-402 mg/dL). The median CD4 count at diagnosis of ICL and at the last available measurement was 82 (range, 7-292) and 132 (range, 13-892) cells/mm, respectively, for an average follow-up of 32 months in 46 patients. Unlike previously normal patients with cryptococcosis, those with ICL had an excess incidence of dermatomal zoster (7 episodes in 46 ICL cases). Pneumocystis pneumonia was rare (1 case), casting doubt on the need for prophylaxis in patients with ICL. A favorable outcome (cured or improved) may be more common in ICL patients than in previously normal patients with cryptococcal meningitis and no predisposing factors. Identification of ICL in patients who were apparently normal before the onset of cryptococcosis appears to be useful because it predicts a favorable outcome. Patients with cryptococcal infection and ICL have an increased likelihood of developing dermatomal zoster. The long-term follow-up of these patients offers some reassurance regarding favorable prognosis.
我们回顾了过去12年转诊至我院的11例隐球菌病合并特发性CD4淋巴细胞减少症(ICL)患者的病例,以及文献报道的42例类似病例,以评估该人群感染的特征。53例ICL患者的隐球菌病与既往正常患者的隐球菌病有共同特征。ICL患者男性略占优势(1.2:1),中位发病年龄为41岁(范围4.5 - 85岁)。初始脑脊液检查结果显示,60%的患者葡萄糖低于40mg/dL,中位细胞增多为59个白细胞/mm(范围0 - 884),蛋白质为156mg/dL(范围25 - 402mg/dL)。46例患者平均随访32个月,诊断ICL时及最后一次可用测量时的CD4细胞计数中位数分别为82(范围7 - 292)和132(范围13 - 892)个细胞/mm。与既往正常的隐球菌病患者不同,ICL患者带状疱疹发病率过高(46例ICL病例中有7例发作)。肺孢子菌肺炎罕见(1例),这使人怀疑ICL患者是否需要预防。ICL患者可能比既往无易感因素的正常隐球菌性脑膜炎患者更易出现良好结局(治愈或改善)。在隐球菌病发作前看似正常的患者中识别出ICL似乎很有用,因为这预示着良好的结局。隐球菌感染合并ICL的患者发生带状疱疹的可能性增加。对这些患者的长期随访为良好预后提供了一些保障。